← Back to catalogue
Published

isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway

vr.tr.isopentenyl-diphosphate-biosynthetic-process-methylerythrito · thing-q21198649

Enable an agent to recognize MEP-pathway production of isopentenyl diphosphate, assess its activity in a specified biological system, and identify justified measurements or interventions.

Thing Registry Activities and processes ACT.PRC

Bundle → Layer → Finding → Questions Filled

6 bundles · 12 layers · 17 findings · 29 questions

MEP route identity Criteria for recognizing this specific route and delimiting its output.

Route membership

Evidence connecting the observed process to MEP chemistry.

MEP-specific continuity

Record the conversions supporting route identity and explicitly mark unobserved links.

  1. Which observed reactions or labeled intermediates establish passage through MEP? definition
  2. Which experiment supports this assignment beyond detecting IPP or predicting homologous genes? provenance

Precursor output boundary

Separate IPP formation from associated C5 interconversion and downstream use.

Terminal output accounting

Represent terminal production and subsequent IPP-DMAPP interconversion separately so pathway boundaries remain explicit.

  1. Does the reported endpoint measure terminal-reaction IPP production, net IPP accumulation, or incorporation into downstream products? boundary
  2. How are associated DMAPP production and later isomerization accounted for? measurement
Reaction chain realization Organism-specific implementation of the reference reaction sequence.

DXP to MEP entry

Define precursor supply and entry into MEP chemistry.

Entry reaction assignment

The reference module includes DXP synthase and DXP reductoisomerase; record their local implementation and precursor interfaces. [KEGG M00096](https://www.kegg.jp/entry/M00096)

  1. Which evidence establishes precursor delivery to DXP formation in this system? provenance
  2. Which enzyme or demonstrated alternative carries out DXP-to-MEP conversion? definition

MEP to HMBPP continuity

Assess the intervening conversions that connect MEP to the terminal substrate.

Intermediate conversion coverage

Map cytidylyltransferase, kinase, cyclodiphosphate synthase, and HMBPP synthase activities to local evidence. [KEGG M00096](https://www.kegg.jp/entry/M00096)

  1. Which intervening activities are demonstrated, predicted, or unresolved? provenance
  2. Do fused proteins, alternative enzymes, or incomplete annotations explain apparent gaps? boundary

HMBPP conversion

Assess the terminal reaction and its measured products.

Terminal reductase evidence

Record HMBPP reductase assignment and direct evidence for terminal product formation. [KEGG M00096](https://www.kegg.jp/entry/M00096)

  1. What supports catalytic activity of the assigned terminal reductase under the stated conditions? provenance
  2. Were IPP and DMAPP resolved and quantified separately in the terminal-reaction assay? measurement
Cellular context and resources Location and enabling conditions for the pathway instance.

Compartmental realization

Anchor the pathway to a specific biological location.

Colocation and exchange

Record enzyme localization, metabolite accessibility, and any transport assumptions connecting reactions.

  1. Which organism, cell type, and compartment contain the claimed pathway instance? definition
  2. Which reaction connections require transport, and what evidence supports that exchange? boundary

Catalytic resource support

Track the resources needed by the locally implemented reactions.

Resource dependency assessment

Record reaction-specific nucleotide, reducing-equivalent, cofactor, and electron-delivery requirements without assuming identical implementations across organisms.

  1. Which resource and cofactor requirements are experimentally established for the local enzymes? provenance
  2. What measurements distinguish resource limitation from insufficient catalytic capacity? measurement
Flux and route attribution Evidence that this route contributes to IPP production and the size of that contribution.

Pool versus throughput

Separate metabolite abundance from production rate.

Flux measurement validity

Require a time basis, normalization, analytical specificity, and stated assumptions for inferred MEP throughput.

  1. Does the experiment measure a metabolite pool, turnover, or pathway-attributed production rate? measurement
  2. How do sampling, detection limits, and uncertainty affect the inferred flux? measurement

Alternative source separation

Resolve MEP contributions where other routes or imported precursors may contribute.

IPP origin discrimination

Record evidence separating local MEP synthesis from mevalonate-derived or externally supplied precursor contributions.

  1. What tracing or perturbation evidence distinguishes MEP-derived IPP from other sources? provenance
  2. Could precursor exchange or mixed cell populations explain the apparent pathway contribution? boundary
Pathway control and perturbation Context-specific evidence for altering MEP output and interpreting the consequences.

Control point assessment

Connect changes in particular reactions to changes in pathway output.

Conditional flux control

Treat control by an entry, intermediate, or terminal reaction as a condition-specific hypothesis requiring perturbation evidence.

  1. Which targeted change altered MEP-attributed flux under matched conditions? provenance
  2. What additional measurement would distinguish a catalytic bottleneck from altered substrate supply or product consumption? action

Response and compensation

Evaluate pathway-specific effects and possible compensation after intervention.

Perturbation causal assessment

Link target engagement, intermediate changes, precursor output, and downstream effects while recording possible alternative explanations.

  1. What establishes that the intervention affected the intended MEP reaction? provenance
  2. Could alternative IPP supply, altered uptake, or general physiological impairment explain the response? boundary
  3. Which control or rescue observation would most directly test the proposed causal explanation? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these typical measurements hold for the sense of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Activities and processes
Entry kind
thing
Plane
ACT
Domain
ACT.PRC
Other names and narrower kinds
isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process

What it is Filled

The methylerythritol 4-phosphate (MEP) pathway is a sequence of enzymatic reactions that converts pyruvate and glyceraldehyde 3-phosphate into the isoprenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), operating in many bacteria and in the plastids of plants and various algae.

In scope

  • Reaction continuity from precursor entry through MEP intermediates to IPP production.
  • Enzyme-function assignments and evidence for missing or alternative implementations.
  • Organism, compartment, physiological condition, and observation interval defining an instance.
  • Intermediate pools, pathway-specific flux, and associated DMAPP output.
  • Resource dependencies, competing precursor sources, and experimentally supported perturbation responses.

Out of scope

  • The broader class of IPP biosynthetic processes and its shared properties.
  • Mevalonate-pathway chemistry, except as an alternative source requiring attribution.
  • Standalone models of IPP, MEP, enzymes, genes, or organisms.
  • Downstream prenyl-chain elongation and synthesis of individual terpenoids.
  • General central-carbon metabolism and organelle transport mechanisms beyond their pathway interfaces.

Why it exists Filled

Enable an agent to recognize MEP-pathway production of isopentenyl diphosphate, assess its activity in a specified biological system, and identify justified measurements or interventions.

Distinguishing features Filled

  • Require evidence for a route through MEP intermediates; IPP detection alone cannot distinguish the MEP and mevalonate routes. [KEGG terpenoid backbone biosynthesis](https://www.genome.jp/pathway/map00900)
  • Check continuity through DXP reductoisomerase, the intervening MEP reactions, and HMBPP synthesis and reduction. [KEGG M00096](https://www.kegg.jp/entry/M00096)
  • Distinguish terminal HMBPP conversion from IPP-DMAPP isomerization, which KEGG also includes in its broader C5 module. [KEGG M00096](https://www.kegg.jp/entry/M00096)
  • Treat gene annotation as evidence of potential capacity; require condition-specific biochemical evidence before classifying an instance as actively producing IPP.
  • Keep production of the C5 precursor distinct from downstream incorporation into larger isoprenoids. [KEGG terpenoid backbone biosynthesis](https://www.genome.jp/pathway/map00900)

What robots and AI may and may not do Filled

Must not

  • Annotate an organism as having the pathway without evidence.
  • Confuse it with the mevalonate pathway that makes the same precursors.
  • Overstate early research on pathway inhibitors as proven medicines or herbicides.

Only with a human decision

  • Releasing engineered organisms that carry modified versions of the pathway.

May

  • Describe the MEP pathway's steps and enzymes from scientific sources.
  • Annotate genes and organisms as having the pathway when evidence supports it.

Moral aspects Filled

  • The pathway is a target for antimalarial drugs and herbicides, whose claims need honest evidence.

Who is affected

  • Researchers
  • Patients awaiting new drugs

Owners Filled

Steward

Nobody owns the process; biological databases curate its annotations.

Master systems

  • Gene and pathway annotation databases

Links to other meta-models Filled

parent

  • Q14865379 - registry parent class
  • Q21438305 - registry parent class
  • Q22282900 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.isopentenyl-diphosphate-biosynthetic-process-methylerythrito
  • Wikidata: Q21198649 (https://www.wikidata.org/wiki/Q21198649)

Direct properties not applicable Not applicable

  • Biological realization: Organism or strain, tissue or cell type, compartment, and native or engineered context
  • Reaction coverage: Each required conversion: experimentally supported, predicted, unresolved, or demonstrated unavailable
  • Activity assessment: Capacity only, activity demonstrated, activity below detection, or unresolved; qualified by conditions
  • MEP-attributed IPP production rate: nmol IPP per mg protein per minute, or another explicitly stated normalization; uncertainty required
  • Intermediate abundance: Concentration or normalized amount for identified DXP, MEP, downstream intermediates, and HMBPP
  • IPP-to-DMAPP output ratio: Molar ratio, with terminal-reaction output distinguished from the subsequent cellular pool ratio
  • Route attribution evidence: Annotation, enzyme assay, metabolite identification, isotope tracing, perturbation, or convergent evidence
  • Perturbation response: Change in pathway-attributed flux or intermediate abundance relative to a matched control, with exposure and duration

Plane ACT: no invented physical properties.

Recognition optional Filled

  • Drawn as a sequence of enzyme steps from pyruvate and glyceraldehyde 3-phosphate to isoprenoid precursors.
  • Found in most bacteria, plant plastids and malaria parasites, not in animals.

Capabilities and actions required Filled

  • Classify evidence as supporting MEP-pathway capacity, observed activity, or an unresolved assignment.
  • Identify gaps in the reaction chain and select evidence needed to resolve them.
  • Compare pathway-attributed IPP production across matched conditions.
  • Distinguish changed intermediate pools from changed biosynthetic flux.
  • Evaluate proposed perturbations against target engagement, resource dependencies, and alternative precursor supply.
  • Link the registered process to neighboring models of enzymes, metabolites, transport, and downstream synthesis.

Hazards and failure modes required Filled

  • Wrong annotations propagate across genome databases.

Standards and interfaces required Filled

  • The Gene Ontology Consortium provides the biological process classification for isopentenyl diphosphate biosynthesis through the methylerythritol 4-phosphate pathway.

Context of use required Filled

  • This pathway occurs in many bacteria and in the plastids of plants and various algae, where it supplies precursors for isoprenoid synthesis.
  • It is studied in microbial physiology, plant metabolism and biotechnology to understand precursor production and its contribution to downstream compounds.

Sources Filled

  1. Wikidata item Q21198649: isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway - identity and sense of the item
  2. Wikipedia: Non-mevalonate pathway - general description of the item

Open questions

  • Should the registry boundary include precursor formation through DXP synthase, and how should it align with reference modules that also include IPP-DMAPP isomerization?
  • Which organism-specific alternative enzymes or fused activities must be supported before reaction coverage can be judged reliably?
  • Which compartments exchange intermediates or C5 precursors in the intended biological systems, and how much does that exchange affect route attribution?
  • Which resource dependencies and control points are experimentally established for each intended context rather than extrapolated from another organism?
  • What minimum combination of tracing, analytical resolution, and perturbation evidence should qualify an instance as actively producing IPP through the MEP pathway?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q21198649/spec.json